Clinical Trials Logo

Gender Dysphoria clinical trials

View clinical trials related to Gender Dysphoria.

Filter by:

NCT ID: NCT04979338 Recruiting - Gender Dysphoria Clinical Trials

Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries

Start date: November 11, 2021
Phase: Phase 3
Study type: Interventional

This study will compare the current standard-of-care pain treatment regimen options that are available to patients who undergo gender-affirming surgery. The purpose of this research is to determine if any of these options are more (versus less) effective than the others to manage surgery related pain, after surgery.

NCT ID: NCT04935164 Recruiting - Clinical trials for Gender Dysphoria, Adult

Comparative Study of Gender Identity Disorder Versus Control

TRANSIDENT
Start date: March 26, 2021
Phase:
Study type: Observational

Gender dysphoria is manifested by an internal tension between biological sex and gender, that is, by a non-congruence, in the subjects who suffer from it, between their sex of birth and their social gender identity.

NCT ID: NCT04736797 Recruiting - Gender Dysphoria Clinical Trials

Transition in Transgender

Start date: November 27, 2020
Phase:
Study type: Observational

The aim of this longitudinal, observational study is to investigate the effects of gender-affirming hormone treatment in FTM (female to male) and MTF (male to female) transgender (TG) people with regard to changes in brain structure and function as well as psychological and behavioral consequences. Methodological problems and missing studies in this area were mentioned several times with an emphasis on the need for longitudinal research.

NCT ID: NCT04708600 Completed - Gender Dysphoria Clinical Trials

Effectiveness of Speech Therapy in Trans Women.

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

One of the greatest hurdles in the transition of transgender persons is that voice, speech and communication are not congruent with the desired gender. Since hormone treatment does not affect the voice in male-to-female transgender persons (trans women), speech therapy is the treatment of choice to develop a more feminine communication. Speech therapy must focus on aspects of communication that play an important role in listener perceptions of the speakers gender. Results of a systematic review and meta-analysis showed that those aspects are primarily fundamental frequency of the voice and resonance. However, effectiveness studies of speech interventions in transwomen are extremely limited and show methodological limitations. The purpose of this project is to investigate the short-term and longterm impact of speech exercises for pitch and resonance on (a) acoustic voice characteristics, (b) listener perceptions of femininity using a visual analogue scale and binary gender identification (male versus female voice), and (c) self-perception and psychosocial functioning in trans women using a randomized sham-controlled trial and cross-over design.

NCT ID: NCT04596592 Recruiting - Insulin Sensitivity Clinical Trials

Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

PUBERTY
Start date: February 15, 2021
Phase:
Study type: Observational

To evaluate the effect of estradiol with or without a prior gonadotropin releasing hormone analogue on insulin sensitivity and vascular function in transgender females compared to cisgender controls.

NCT ID: NCT04573127 Active, not recruiting - Gender Dysphoria Clinical Trials

Gender Dysphoria: Epidemiological Data

DyGenEpi
Start date: July 27, 2020
Phase:
Study type: Observational

Retrospective study in a single academic regional transgender referral center. data from the cohort follow-up in CHRU de Nancy

NCT ID: NCT04554849 Active, not recruiting - Gender Dysphoria Clinical Trials

Demographic Characteristics and Psychosocial Health of Transgender People

DyGeDem
Start date: July 24, 2020
Phase:
Study type: Observational

To study demographic characteristics of subjects referred to endocrine care for gender dysphoria and their psychosocial health

NCT ID: NCT04551144 Terminated - Transgenderism Clinical Trials

Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors

Start date: October 6, 2020
Phase:
Study type: Observational

The purpose of this research is to find out if hormone therapy in transgender subjects' changes hormone receptors in blood, muscle and fat; fat production; muscle production; and inflammation processes.

NCT ID: NCT04508231 Active, not recruiting - Gender Dysphoria Clinical Trials

Metabolic Consequences of Cross-sex Hormonal Treatment

DysGeMet
Start date: July 24, 2020
Phase:
Study type: Observational

Retrospective study in a single academic regional transgender referral center. Analyse VAT, body composition and metabolic parameters in non-obese transgender subjects one year after starting gender-affirming hormone therapy and in controls

NCT ID: NCT04478214 Completed - Gender Dysphoria Clinical Trials

The Strategic Use of Hyaluronic Acid Fillers and Neurotoxin to Influence Gender Perception in Transgender Individuals

Start date: August 13, 2019
Phase:
Study type: Observational

Observational survey study of transgender individuals who have undergone cosmetic neurotoxin and soft tissue filler for the purpose of influencing gender perception.